Cell Source Inc (CLCS) 1.1600 $CLCS Cell Source

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cell Source Inc (CLCS) 1.1600 $CLCS

Cell Source Improving Immunotherapy with T-Cell Twist
ACCESSWIRE - Tue Apr 26, 7:00AM CDT
NEW YORK, NY / ACCESSWIRE / April 26, 2016 / Immunotherapy is undoubtedly one of the most talked about and promising areas in biotechnology today. As the library of research continues to grow, combination therapies are emerging to hopefully deliver more clinically meaningful outcomes. This is exemplified by the recent pact between Kite Pharma (NASDAQ: KITE) and Roche's (OTCQX: RHHBY) Genentech to collaborate (http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=961129) on using Kite's experimental CAR-T (chimeric antigen-receptor T cell) treatment, KTE-C19, in combination with Roche's PD-L1 (programmed death ligand-1) immunotherapy, atezolizumab, in patients suffering from refractory, aggressive non-Hodgkin lymphoma (NHL).
KITE: 54.57 (-0.36), AMGN: 174.80 (-0.82), TEVA: 51.47 (+0.24)

Cell Source to Present at the LD Micro Main Event
Marketwired - Fri Nov 27, 8:34AM CST
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced that it will be presenting at the 8th annual LD Micro Main Event on Thursday, December 3rd at 4PM PST. Itamar Shimrat (CEO of Cell Source) will be giving the presentation and meeting with investors.

Cell Source's Megadose Drug Combination Treats First Patient
Marketwire Canada - Wed Nov 11, 7:51AM CST
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today initial indications that its Megadose Drug Combination has been used to successfully treat a cancer patient in Italy. Cell Source's proprietary Megadose Drug Combination (licensed exclusively from the Weizmann Institute of Science in Israel) is expected to increase bone marrow transplantation (BMT) success and survival.

Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative
Marketwired - Wed Nov 04, 8:14AM CST
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced their initiative for joint venture Pharma collaborations at their inaugural Scientific Advisory Board (SAB) Summit held in New York City. SAB members are leading experts from Harvard University, Stanford University, Oxford University, Mt. Sinai Medical and University Hospital Wurzburg. They have endorsed Cell Source's pursuit of JV collaborations with major Pharma players. Recent scientific developments and new provisional patent applications have set the stage for these JV Pharma Collaborations to leverage Cell Source's Veto Cell technology and accelerate its commercialization.

Cell Source names Dr Dennis Brown as board chairman
M2 - Thu Aug 20, 3:52AM CDT
Biotechnology company Cell Source(OTC BB:CLCS) reported on Wednesday it has appointed Dr Dennis Brown as the chairman of its board of directors.

Cell Source Appoints Dr. Dennis Brown as Chairman of Its Board of Directors
Marketwired - Wed Aug 19, 8:04AM CDT
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Dennis Brown, currently a Director of Cell Source, has been appointed Chairman of the Board of Directors.

Cell Source Appoints Dr. Robert Negrin to Its Scientific Advisory Board
Marketwired - Mon Jul 06, 7:31AM CDT
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Robert S. Negrin, Director of the Bone and Marrow Transplantation Division and Professor of Medicine at Stanford University, has joined its Scientific Advisory Board.

Cell Source Appoints Dr. Steven Burakoff to Its Scientific Advisory Board
Marketwired - Mon Jun 29, 7:30AM CDT
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Steven Burakoff, Director of the Tisch Cancer Institute at Mount Sinai Medical Center and Professor of Cancer Medicine and Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai, has joined its Scientific Advisory Board.

World Class Immunologist Dr. Herman Waldmann Joins Cell Source's Scientific Advisory Board
Marketwired - Wed Jun 17, 7:31AM CDT
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Herman Waldman, who served as Department Head and Professor Emeritus of Pathology at the Oxford Medical School and Clinical Director of Oxford's Therapeutic Antibody Centre, has joined the Cell Source Scientific Advisory Board.

Cell Source names Dr Terry Strom as SAB chair
M2 - Fri Jun 05, 4:52AM CDT
Biotechnology company Cell Source (OTCBB:CLCS) revealed on Thursday the addition of Dr Terry Strom as chairman of its Scientific Advisory Board (SAB).

Cell Source Appoints Dr. Terry Strom as Chairman of Its Scientific Advisory Board
Marketwired - Thu Jun 04, 10:22AM CDT
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Terry Strom, Professor of Medicine and Surgery at Harvard Medical School and Director of The Transplant Institute at Beth Israel Deaconess Medical Center, has been retained to serve as Chairman of its Scientific Advisory Board.

Cell Source to Present at the 2015 Marcum MicroCap Conference
Marketwired - Fri May 22, 1:01PM CDT
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that it will present at the 2015 Marcum MicroCap Conference on Thursday, May 28th, 2015 in New York City at the Grand Hyatt Hotel.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 110

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 123

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 87

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Five Films Put Modern Infrastructure Under a Lens

Updated Category News Views 121

Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...

Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem

Updated Category News Views 100

A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 108

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 93

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading

Top 5 Most Recently Viewed Articles

McDonald's Earnings Anticipation: Insights from Analysts Ahead

Updated Category News Views 110

Anticipating McDonald's Q3 Earnings Report As the third quarter approaches, McDonald's Corporation (NYSE: MCD) is preparing to unveil its earnings report, sparking interest among investors and analysts alike. This significant event is anticipated to occur just before the opening bell, offering crucial insights into the company's financial health and market position. What...

Continue Reading
BC Platforms Unveils Game-Changing AI Technology for Researchers

Updated Category News Views 281

BC Platforms Introduces BC Catalyst for Precision Medicine BC Platforms has officially launched BC Catalyst, an innovative AI-native analytics product designed to enhance precision medicine. This breakthrough technology integrates genomic and real-world data, allowing for actionable insights throughout the entire drug lifecycle. With BC Catalyst, the company aims to...

Continue Reading
TestFly Expands QA Testing Services with Red Cerberus Deal

Updated Category News Views 300

TestFly Enhances Service Offerings Through Acquisition TestFly, a prominent provider of innovative quality assurance testing solutions for the video game and mobile gaming sectors, has undertaken a significant move by acquiring Red Cerberus. This acquisition is set to transform the landscape of video game quality assurance by integrating Red Cerberus' expertise and...

Continue Reading
Unveiling Insurance Industry Abuses: New Podcast Series Launch

Updated Category News Views 173

Consumer Watchdog Introduces Insightful Podcast Series Smoke & Mirrors Debuts Today, Investigating Insurance Underpayments and Consumer Resilience Today marks the launch of a groundbreaking podcast series from Consumer Watchdog, titled "Smoke & Mirrors: Investigating Home Insurance Abuses," aimed at shedding light on the troubling practices that major insurance firms...

Continue Reading
MongoDB’s Leadership Change: Opportunities for Investors Ahead

Updated Category News Views 171

Understanding the Leadership Shift at MongoDB Recently, MongoDB (NASDAQ: MDB) has been a significant topic of discussion in investing circles due to its remarkable stock performance. After the stock's impressive rise from $188.81 to about $358 per share, many are questioning the right strategy—should investors lock in their profits now or remain committed for the long...

Continue Reading